1. Home
  2. THTX vs RDIB Comparison

THTX vs RDIB Comparison

Compare THTX & RDIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THTX
  • RDIB
  • Stock Information
  • Founded
  • THTX 1993
  • RDIB 1937
  • Country
  • THTX Canada
  • RDIB United States
  • Employees
  • THTX N/A
  • RDIB N/A
  • Industry
  • THTX Biotechnology: Pharmaceutical Preparations
  • RDIB Movies/Entertainment
  • Sector
  • THTX Health Care
  • RDIB Consumer Discretionary
  • Exchange
  • THTX Nasdaq
  • RDIB Nasdaq
  • Market Cap
  • THTX 119.1M
  • RDIB 140.2M
  • IPO Year
  • THTX N/A
  • RDIB N/A
  • Fundamental
  • Price
  • THTX $3.16
  • RDIB $9.20
  • Analyst Decision
  • THTX Hold
  • RDIB
  • Analyst Count
  • THTX 1
  • RDIB 0
  • Target Price
  • THTX N/A
  • RDIB N/A
  • AVG Volume (30 Days)
  • THTX 1.0M
  • RDIB 11.7K
  • Earning Date
  • THTX 07-09-2025
  • RDIB 08-13-2025
  • Dividend Yield
  • THTX N/A
  • RDIB N/A
  • EPS Growth
  • THTX N/A
  • RDIB N/A
  • EPS
  • THTX N/A
  • RDIB N/A
  • Revenue
  • THTX $84,378,000.00
  • RDIB $205,644,000.00
  • Revenue This Year
  • THTX N/A
  • RDIB $7.47
  • Revenue Next Year
  • THTX $15.13
  • RDIB $13.22
  • P/E Ratio
  • THTX N/A
  • RDIB N/A
  • Revenue Growth
  • THTX 2.19
  • RDIB N/A
  • 52 Week Low
  • THTX $1.12
  • RDIB $5.78
  • 52 Week High
  • THTX $3.20
  • RDIB $21.34
  • Technical
  • Relative Strength Index (RSI)
  • THTX 73.38
  • RDIB 40.94
  • Support Level
  • THTX $3.14
  • RDIB $9.30
  • Resistance Level
  • THTX $3.20
  • RDIB $11.82
  • Average True Range (ATR)
  • THTX 0.06
  • RDIB 0.64
  • MACD
  • THTX 0.06
  • RDIB -0.05
  • Stochastic Oscillator
  • THTX 94.93
  • RDIB 10.28

About THTX Theratechnologies Inc.

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

About RDIB Reading International Inc Class B

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.

Share on Social Networks: